'Hepatoma-specific' alphafetoprotein may permit preclinical diagnosis of malignant change in patients with chronic liver disease.

The only hope for effective treatment of hepatocellular carcinoma (HCC or 'hepatoma') lies in early diagnosis. Measurement of the serum alphafetoprotein (AFP) level is potentially a useful screening test. When grossly raised, it is almost diagnostic of HCC. However, modestly elevated level...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, P. J., Leung, N., Cheng, P., Welby, C., Leung, W. T., Lau, W. Y., Yu, S., Ho, S.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group|1 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063272/
https://www.ncbi.nlm.nih.gov/pubmed/9010032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063272/
https://www.ncbi.nlm.nih.gov/pubmed/9010032

Ejemplares similares